All companies
🇦🇹
🇦🇹Nineteen Twenty-One
Vienna venture fund backing early-stage companies in type 1 diabetes and the diseases that come with it.
Startup🇦🇹 Vienna, Austria
2024Founded
About
Nineteen Twenty-One (1921) is a venture fund in Vienna focused on type 1 diabetes and related cardiovascular, renal, neurodegenerative and metabolic disease. It was founded by Fredrik Debong, co-founder of mySugr, hi.health and Pioneers. It invests from first money in up to select Series A rounds, globally, with most of its capital going to the EU. It is an EuVECA-registered fund and works with a network of clinicians, researchers, patients and investors. The name refers to 1921, the year insulin was discovered.
Featured work
Team
Open to
Speakers for events
Founders can book a meeting through the fund's site. The fund says an intro through shared friends helps. Fredrik Debong spoke at a Founder Institute Japan online event in February 2025.In the company's own words
Openfor.co network
Put your company on Openfor. Get found.
Show your products, customers and traction to founders, investors and partners across 30+ countries.

